We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The FDA released new draft guidance for devicemakers on submitting premarket notifications for metal expandable biliary stents and their delivery systems. Read More
IMDRF’s Adverse Event Terminology Working Group is seeking comments on proposals to harmonize terminology globally for reporting adverse events for medical devices and in vitro diagnostics. Read More
Bayer announced it would stop selling its Essure permanent birth control device after Dec. 31 and the FDA said it expects the company to meet its postmarket obligations. Read More
Brazil released its first requirements for unique device identifiers for high-risk medical devices that are slated to go into effect in 2020. Read More
In response to a request for information on medical device cybersecurity by the House Energy and Commerce Committee, stakeholders called for additional guidance and funding to help resolve cybersecurity flaws. Read More
The company will pay $11.5 million to resolve allegations that it caused false claims to be submitted to government healthcare programs for procedures involving an unapproved drug-delivery device. Read More